# Hawthorne Effect

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hawthorne-effect

- Industry: Healthcare
- Headquarters: Lafayette, US
- Website: www.hawthorne-effect.com
- Total disclosed funding: $20M
- Latest round: Series A (Jun 9, 2021)
- Investors on record: 3

## About

Hawthorne Effect Inc. is a US-based company that specializes in conducting inclusive clinical trials through a network of community research sites, focusing on accessibility and diverse patient populations.Founded in 2015 in Lafayette, US, Hawthorne Effect Inc. facilitates clinical trials with a focus on inclusivity. The company has undergone no notable pivots since inception. Jodi Akin, the founder, has a history of entrepreneurial efforts. In June 2021, the company raised USD 20 mn in a Series A funding round led by Northpond Ventures, with participation from P5 Health Ventures and existing investor SignalFire. This funding represents the total amount raised by the company so far.Hawthorne Effect Inc. specializes in facilitating inclusive and transformative clinical trials by leveraging a robust network of 75 community-based research sites across the United States. Their core offerings include a home visit solution, enabling clinical trials in patients' homes, thereby enhancing accessibility and reducing enrollment barriers. This approach targets diverse patient populations across therapeutic areas such as cardiovascular, neurology, and rare diseases, ensuring high-quality data collection from broad demographics. The company's services aim to improve patient care and compliance while delivering actionable insights and real-world data to sponsors and researchers.Hawthorne Effect Inc. generates revenue through partnerships with study sponsors, granting them access to its extensive community research network and clinical trial solutions. The company operates primarily on a B2B model, collaborating with pharmaceutical companies and research organizations to conduct tailored clinical trials. Revenue comes from contractual agreements detailing service fees for trial management, patient recruitment, and data collection based on the individual studies' scope and requirements.In June 2021, Hawthorne Effect Inc. raised USD 20 mn in Series A funding, aimed at accelerating growth and scaling operations. The company plans to expand its product offerings and enhance its existing clinical trial solutions. Specific future products may be designed to further improve patient engagement and participation rates. Additionally, expansions into new markets and geographic regions are anticipated to increase reach, although specific locations have yet to be disclosed. The recent funding will support these initiatives to enhance the overall efficiency and effectiveness of clinical trials.

## Funding rounds

- Series A, Jun 9, 2021, $20M — SignalFire, P5 Health Ventures, Northpond Ventures

## Investors

- SignalFire (https://capitalatlas.ai/funds/signalfire) — Series A
- P5 Health Ventures (https://capitalatlas.ai/funds/p5-health-ventures) — Series A
- Northpond Ventures (https://capitalatlas.ai/funds/northpond-ventures) — Series A